|
|
|
Insider
Information: |
Winningham Rick E |
Relationship: |
|
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,688,476 |
|
Indirect Shares
|
96,467 |
|
|
Direct
Value |
$31,541,999 |
|
|
Indirect Value
|
$896,178 |
|
|
Total
Shares |
2,784,943 |
|
|
Total
Value |
$32,438,177 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-15.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Innoviva Inc |
INVA |
Director |
2014-08-15 |
825,391 |
2008-01-29 |
0 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
10,444 |
2012-01-11 |
0 |
Premium* |
|
Theravance Biopharma, Inc. |
TBPH |
|
2024-05-15 |
1,852,641 |
2024-05-15 |
96,467 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
131 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2021-05-20 |
4 |
D |
$17.80 |
$202,991 |
D/D |
(11,404) |
1,324,818 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2020-08-20 |
4 |
D |
$18.22 |
$254,096 |
D/D |
(13,946) |
1,289,115 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2012-02-20 |
4 |
D |
$18.54 |
$396,496 |
D/D |
(21,386) |
469,302 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2021-02-20 |
4 |
D |
$18.79 |
$2,073,439 |
D/D |
(110,348) |
1,334,821 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2015-02-20 |
4 |
D |
$19.52 |
$28,890 |
D/D |
(1,480) |
520,158 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2019-05-20 |
4 |
D |
$19.84 |
$172,172 |
D/D |
(8,678) |
1,091,811 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2012-05-20 |
4 |
D |
$20.33 |
$217,145 |
D/D |
(10,681) |
521,846 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-23 |
4 |
AS |
$21.14 |
$2,063,264 |
D/D |
(97,600) |
556,273 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-22 |
4 |
AS |
$21.43 |
$3,624,800 |
D/D |
(168,800) |
511,373 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-24 |
4 |
AS |
$21.45 |
$1,996,995 |
D/D |
(93,100) |
599,123 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2019-08-20 |
4 |
D |
$21.51 |
$186,664 |
D/D |
(8,678) |
1,083,133 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2013-02-20 |
4 |
D |
$22.10 |
$235,476 |
D/D |
(10,655) |
591,922 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-25 |
4 |
AS |
$22.22 |
$2,070,524 |
D/D |
(92,200) |
642,773 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-11-20 |
4 |
D |
$22.34 |
$138,910 |
D/D |
(6,218) |
479,688 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-28 |
4 |
AS |
$22.49 |
$1,544,030 |
D/D |
(67,000) |
677,525 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-20 |
4 |
D |
$22.50 |
$152,775 |
D/D |
(6,790) |
422,033 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2010-11-20 |
4 |
D |
$22.52 |
$125,099 |
D/D |
(5,555) |
181,323 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-03-01 |
4 |
AS |
$22.53 |
$1,439,059 |
D/D |
(63,873) |
613,652 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-05-20 |
4 |
D |
$24.31 |
$1,643,769 |
D/D |
(67,617) |
919,620 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2017-08-11 |
4 |
B |
$24.50 |
$245,000 |
D/D |
10,000 |
866,377 |
2.81 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-11-20 |
4 |
D |
$24.79 |
$385,658 |
D/D |
(15,557) |
795,939 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2020-02-20 |
4 |
D |
$25.90 |
$2,508,415 |
D/D |
(96,850) |
1,315,605 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-05-11 |
4 |
AS |
$26.28 |
$1,921,068 |
D/D |
(73,100) |
485,906 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-05-10 |
4 |
AS |
$26.41 |
$1,443,201 |
D/D |
(54,646) |
559,006 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2020-05-20 |
4 |
D |
$26.67 |
$371,940 |
D/D |
(13,946) |
1,303,061 |
0 |
- |
|
131 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|